Search Results

1 - 10 of 2,794 items :

Clear All

R eferences 1. Casadaban LC, Parvinian A, Couture PM et al . Investigation of epidemiology and etiology of liver diseases and characterization of its association with various factors. Asian J Pharm Clin Res 8: 346-349, 2015. 2. World Health Organization . Hepatitis C. Available at: . Last accessed: February 2016. 3. World Health Organization . Viral Hepatitis requires more attention in the WHO European region. Available at: http

References 1. G. OZTURK, B. AYDINLI, M. I. YILDIRGAN, et al., “Posttraumatic free intraperitoneal rupture of liver cystic echinococcosis: a case series and review of literature,” American Journal of Surgery, vol. 194, no. 3, pp. 313-316, 2007 2. A. T. TURGUT, L. ALTIN, S. TOPÇU, et al., “Unusual imaging characteristics of complicated hydatid disease,” European Journal of Radiology, vol. 63, no. 1, pp. 84-93, 2007 3. S. CHARFI, L. AYADI, N. TOUMI, et al., “Cystic undifferentiated sarcoma of liver in children: a pitfall diagnosis in endemic hydatidosis areas

Introduction Liver cir rhosis (LC) is a common gastroenterological pathology among adults. Its aetiological factors are: alcohol abuse, hepatitis B infection, hepatitis C infection, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and others.[ 1 , 2 ] Cirrhosis with multiple-aetiologies are more susceptible of developing multiple organ failures, predominantly kidney, brain, heart and others.[ 1 , 3 ] This disease can be classified using several methods and these cases will be focusing on Halstead-Reitan and Child-Pugh score classification

REFERENCES 1. Blachier M, Leleu H, Peck-Radosavljevic M. The burden of liver disease in Europe: A review of available epidemiological data. J Hepatology, 58, 2013, № 3, 593-608. 2. Elpek G. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol, 20, 2014, № 23, 7260-7276. 3. Göbel T, Erhardt A, Herwig M, et al. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe. J Med Virol, 83, 2011, № 6, 968-973. 4. Hernandez-Gea V, Scott L. Friedman SL

REFERENCES 1. Sawczuk-Chabin J, Centkowski P, Biliński P, Warzocha K. Epidemiology of non-Hodgkin lymphomas. Acta Haematoa Poa . 2004;35 2):131-144. 2. Lettieri CJ, Berg BW. Clinical features of non-Hodgkins lymphoma presenting with acute liver failure: a report of five cases and review of published experience. Am J Gastroenterol . 2003;98(7):1641-6. 3. Sass D, Shakil A. Fulminant hepatic failure. Liver Transpl . 2005;11: 594-605. 4. Larson A: Diagnosis and management of acute liver failure. Curr Opin Gastroenterol . 2010; 26:214-221. 5. Pileri SA, Zinzani L

Introduction Liver cirrhosis (LC) is a health problem worldwide. The Global Burden Study 2010 ranks LC as the 23 rd cause of disease burden worldwide causing 31 million global disability-adjusted life years (DALYs), and it is the 12 th cause of mortality with more than one million deaths per year.[ 1 , 2 ] The most common etiologies leading to chronic damage and LC are excessive alcohol consumption, hepatitis C virus (HCV) infection or hepatitis B virus (HBV) infection, and most recently the nonalcoholic steatohepatitis (NASH) due to the global obesity pandemic

References 1. Broelsch CE, Frilling A, Nadalin S, et al. Leberlebendspende. Die deutsche Erfahrungim international Vergleich. Chirurg. 2003;74(6):510-522. 2. Shiffman ML, Brown RS Jr, Olthoff KM, et al. Lving donor liver transplantation: Summary of a conference at the National Institutes of Health. Liver Transplantation. 2002;8(2):174-188. 3. Malago M, Testa G, Frilling A, et al. Right living donor liver transplantation: An Option for Adult Patients. Annals of Surgery. 2003;238(6):853-863. 4. Marcos A. Right lobe living donor liver transplantation: A Review

References Abbasoglu, O. (2008). Liver transplantation: Yesterday, today and tomorrow. World J. Gastroenterol., 14 , 3117-3122. Abbasoglu, O., Levy, M. F., Brkic, B. B., Testa, G., Jeyarajah, D. R., Goldstein, R. M., Husberg, B. S., Gonwa, T. A., Klintmalm, G. B. (1997). Ten years of liver transplantation: An evolving understanding of late graft loss. Transplantation. 64 (12), 1801-1807. Adam, R., McMaster, P., O'Grady, J. G., Castaing, D., Klempnauer, J. L., Jamieson, N., Neuhaus, P., Lerut, J., Salizzoni, M., Pollard, S. (2003). Evolution of liver

1 Introduction A variety of primary diseases has led Chinese pediatric patients to suffer from liver cirrhosis, especially biliary atresia (BA), which has threatened their health and lifespan; fortunately, significant progress in the field of liver transplantation 1 has made this treatment the most effective therapeutic strategy for pediatric patients with end-stage liver diseases. 2 Several transplantation centers have begun to perform living donor liver transplantation (LDLT) since the first case of pediatric liver transplantation was successfully performed in

REFERENCES 1. THIELE M., KJAERGAARD M., THIELSEN P., KRAG A. Contemporary use of elastography in liver fibrosis and portal hypertension . Clin Physiol Funct Imaging 2017; 37 :235-42. 2. GRUGUREVIC I., BOZIN T., MADIR A. Hepatitis C is now curable, but what happens with cirrhosis and portal hypertension afterwards? Clin Exp Hepatol 2017; 3 :181-6. 3. DOLMAZASHVILI E., ABUTIDZE A., CHKHARTISHVILI N., KARCHAVA M., SHARVADZE L., TSERTSVADZE T. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with